BlackRock Fund Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

BlackRock Fund Advisors’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$117K	Buy	1,807 +43	+2%	+$2.69K	﹤0.01%	3569
2016 Q3	$115K	Sell	1,764 -3	-0.2%	-$193	﹤0.01%	3594
2016 Q2	$131K	Sell	1,767 -11,939	-87%	-$1.2M	﹤0.01%	3589
2016 Q1	$1.56M	Sell	13,706 -560	-4%	-$63.5K	﹤0.01%	3130
2015 Q4	$2.19M	Buy	14,266 +482	+3%	+$72.3K	﹤0.01%	3131
2015 Q3	$1.5M	Buy	13,784 +90	+0.7%	+$11.7K	﹤0.01%	3170
2015 Q2	$1.96M	Buy	+13,694	New	+$3.17M	﹤0.01%	3170

Other funds holding CALA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Fund Advisors's CALA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Calithera Biosciences, Inc (CALA) stake by 2.4% in Q4 2016, buying an estimated $2.69K and bringing the position to 1,807 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

BlackRock Fund Advisors first reported a position in CALA in Q2 2015 and has held it in 7 quarters since. The position peaked at $2.19M in Q4 2015. 33 funds tracked by Wall St. Rank hold CALA as of Q4 2016.

BlackRock Fund Advisors held 1,807 shares of Calithera Biosciences, Inc worth $117K as of Q4 2016.
BlackRock Fund Advisors bought 43 Calithera Biosciences, Inc shares in Q4 2016, an estimated $2.69K.
Calithera Biosciences, Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3569 holding.
BlackRock Fund Advisors first reported a position in Calithera Biosciences, Inc in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's Calithera Biosciences, Inc position peaked at $2.19M in Q4 2015.
33 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.